ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,280.40
-0.13%
Dow Jones
40,421.36
0.33%
Brent Oil
81.44
-0.09%
Bitcoin
66,901.91
-1.04%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zymeworks Inc (ZYME)

  7. Zymeworks Inc (ZYME) News

ZYME

Zymeworks (ZYME)

Zymeworks Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZYME
DateTimeSourceHeadlineSymbolCompany
07/22/20246:00AMGlobeNewswire Inc.Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug ConjugateNASDAQ:ZYMEZymeworks Inc
07/11/20246:30AMGlobeNewswire Inc.Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024NASDAQ:ZYMEZymeworks Inc
06/17/20246:00AMGlobeNewswire Inc.Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing CancersNASDAQ:ZYMEZymeworks Inc
06/10/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
06/10/20246:00AMGlobeNewswire Inc.Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract CancerNASDAQ:ZYMEZymeworks Inc
05/28/20246:30AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
05/02/20244:05PMGlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:ZYMEZymeworks Inc
04/30/20246:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
04/11/20246:00AMGlobeNewswire Inc.Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:ZYMEZymeworks Inc
04/08/20246:00AMGlobeNewswire Inc.Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
03/28/20246:00AMGlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
03/27/20246:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
03/07/20244:46PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZYMEZymeworks Inc
03/07/20244:36PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZYMEZymeworks Inc
03/06/20245:25PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ZYMEZymeworks Inc
03/06/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
03/06/20244:09PMGlobeNewswire Inc.Zymeworks Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ZYMEZymeworks Inc
03/05/20244:30PMGlobeNewswire Inc.Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
02/27/20246:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
02/22/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
02/14/20246:00AMGlobeNewswire Inc.Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference CallNASDAQ:ZYMEZymeworks Inc
02/08/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
02/08/20246:00AMGlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
01/31/20246:00AMGlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
01/08/20246:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
01/05/20249:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
01/05/20249:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
01/05/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
01/04/20246:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
01/04/20246:15AMGlobeNewswire Inc.Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025NASDAQ:ZYMEZymeworks Inc
 Showing the most relevant articles for your search:NASDAQ:ZYME

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GRLT
Grillit (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
CNNA
Cann American (CE)
USOTC
NBRI
North Bay Resources (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
VPLM
Voip Pal Com (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved